Pictet Asset Management Sa Immuno Gen, Inc. Transaction History
Pictet Asset Management Sa
- $83.4 Billion
- Q2 2023
A detailed history of Pictet Asset Management Sa transactions in Immuno Gen, Inc. stock. As of the latest transaction made, Pictet Asset Management Sa holds 721,075 shares of IMGN stock, worth $0. This represents 0.02% of its overall portfolio holdings.
Number of Shares
721,075
Previous 25,809
2693.89%
Holding current value
$0
Previous $99,000
13643.43%
% of portfolio
0.02%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding IMGN
# of Institutions
13Shares Held
1.41MCall Options Held
0Put Options Held
0-
Decheng Capital Management Iii (Cayman), LLC416KShares$03.65% of portfolio
-
Health Cor Management, L.P. New York, NY150KShares$00.7% of portfolio
-
Kellner Capital, LLC New York, NY69.2KShares$03.7% of portfolio
-
Leo Brokerage, LLC25KShares$00.05% of portfolio
-
Baystate Wealth Management LLC24.1KShares$00.05% of portfolio
About ImmunoGen, Inc.
- Ticker IMGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 220,712,992
- Description
- ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...